Protagen Expands Cooperation with Bayer HealthCare
Advertisement
Protagen AG and Bayer HealthCare Pharmaceuticals announced the start of a new collaboration project for the clinical validation of diagnostic biomarkers in endometriosis. This new cooperation project builds on the results of the Endometriosis biomarker discovery study performed last year, and is already the third UNIarray® Project within the collaboration between the two partners in the last three years.
„With the targeted advancement of the UNIarray® technology platform, Protagen has developed into a preferred partner for drug development companies”, states Dr. Peter Schulz-Knappe, CSO and Executive Vice President Diagnostics at Protagen, „now we can directly support our collaboration partners in pharma and biotech in all clinical Phases I-IV with the development of therapy specific diagnostic assays.
Besides Endometriosis, our technology is applied in autoimmune diseases like Multiple Sclerosis, chronic inflammatory diseases and cancer. Cooperation partners are, amongst others, Bayer, Biogen-Idec und SuppreMol.“
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
New insights on how bird flu crosses the species barrier - How a key avian influenza virus enzyme can mutate to allow the virus to replicate in mammals
Sigma-Aldrich and Sangamo BioSciences Announce Alliance to Develop Zinc Finger-Based Laboratory Research Reagents
ABB Robotics and Mettler-Toledo join forces to accelerate global adoption of flexible lab automation - Companies will redefining the limits of robotics in laboratories to accelerate innovation and address labor shortages
Merck Looks Ahead to the Future
Tracking Down Genetic Influences on Brain Disorders
Brain stent offers alternative to shunt for fixing potentially blinding vein narrowing - Pseudotumor cerebri condition marked by excessive pressure in skull, most common in obese, premenopausal women between the ages of 18 and 40